Multiple nurses, multiple IVs, one easy booking
The FDA last week issued warning letters against a handful of companies flagging violations regarding the promotion and sale of unapproved weight-loss drugs, including unlicensed versions of the blockbuster therapies semaglutide and tirzepatide
doi: 10.1038/s41589-020-00734-x 26 BeharierOTyurinVAGoffJPGuerrero-SantoroJKajiwaraKChuTet al
(FDA approved for skin whitening, anti-aging and skin renewal)
Oxidative stress indicators and chemical contaminants in East Pacific green turtles (Chelonia mydas) inhabiting two foraging coastal lagoons in the Baja California peninsula
"And because none of these compounds have gone through rigorous human trials, the long-term effects of chronic use are simply unknown." RFK vows to end FDA war on peptides For years, the Food and Drug Administration has been trying to crack down on the peptides space, sending warning letters to clinics that promote the products and adding more than two dozen peptides to a list of ingredients that should not be made by specialty pharmacies that often custom mix the formulations
